<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">



<DIV style="font-size: 10pt">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>


<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>

<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P align="center" style="font-size: 10pt"><B>Date of Report (Date of earliest event reported): December 31, 2008</B>

<P align="center">

<P align="center" style="font-size: 24pt"><B>Osteotech, Inc.<BR></B>
<FONT style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>Delaware</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>000-19278</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>13-3357370</B></TD>
</TR>
<TR valign="top">
    <TD>(State or other Jurisdiction of Incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD>(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD>(IRS Employer Identification No.)</TD>
</TR>
</TABLE>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="49%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>51 James Way, Eatontown, New Jersey <BR></B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>07724</B></TD>
</TR>
<TR valign="top">
    <TD>(Address of Principal Executive Offices)</TD>
    <TD>&nbsp;</TD>
    <TD>(Zip Code)</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt">Registrant&#146;s telephone number, including area code: <B>(732) 542-2800</B>


<TABLE border="0" width="30%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="100%">&nbsp;</TD>
</TR>
<TR>
    <TD nowrap style="border-bottom: 1px solid #000000"><B>Not Applicable<BR></B></TD>
</TR>
<TR>
    <TD nowrap>(Former name or former address if changed since last report.)</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

<P align="left" style="font-size: 10pt">
<FONT face="Wingdings">&#111;</FONT> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<P>
<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="left" style="font-size: 10pt"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">(e)&nbsp;In October&nbsp;2004, the American Jobs Creation Act of 2004 amended the Internal Revenue Code of 1986, as amended,
to add Section&nbsp;409A (&#147;<I>Section&nbsp;409A</I>&#148;), which imposes significant restrictions on non-qualified deferred compensation.
On December&nbsp;31, 2008, Osteotech, Inc. (the &#147;<I>Company</I>&#148;) and each of Mark H. Burroughs, Robert Honneffer, Sam Owusu&#150;Akyaw
and Robert Wynalek (each an &#147;<I>Executive</I>&#148; and together the &#147;<I>Executives</I>&#148;) entered into an amendment to each of the
Executive&#146;s Employment Agreements and Change in Control Agreements (together, the &#147;<I>Amendments</I>&#148;) to bring the relevant
provisions of their Employment Agreements and Change in Control Agreements into compliance with Section&nbsp;409A. The
Amendments (i)&nbsp;clarify the definition of &#147;Separation From Service&#148; for purposes of the Company&#146;s payment of amounts
subject to Section&nbsp;409A, (ii)&nbsp;revise the provisions regarding separation pay due to involuntary separation from service
without cause so that they qualify for the exemption under Section&nbsp;409A and (iii)&nbsp;clarify when such separation pay
shall be paid.


<P align="left" style="font-size: 10pt; text-indent: 4%">No other terms or conditions of the Employment Agreements or Change in Control Agreements of each of the
Executives were amended by the Amendments.


<P align="left" style="font-size: 10pt; text-indent: 4%">The foregoing summary of the Amendments is qualified in its entirety by reference to the Amendments to each of the
Executive&#146;s Employment Agreements, which are filed as Exhibits 10.1, 10.2, 10.3 and 10.4 to this Current Report on Form
8-K and incorporated herein by reference, and the form of Change in Control Agreement Amendment, which is filed as
Exhibit&nbsp;10.5 to this Current Report on Form 8-K and incorporated herein by reference.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits.</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">(d)&nbsp;Exhibits.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD> Amendment No.&nbsp;2 to Employment Agreement, effective as of December&nbsp;31, 2008, between Osteotech, Inc. and
Mark H. Burroughs.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Amendment No.&nbsp;1 to Employment Agreement, effective as of December&nbsp;31, 2008, between Osteotech,
Inc. and Robert Honneffer.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.3</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Amendment No.&nbsp;2 to Employment Agreement, effective as of December&nbsp;31, 2008, between Osteotech,
Inc. and Sam Owusu&#150;Akyaw.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.4</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Amendment No.&nbsp;1 to Employment Agreement, effective as of December&nbsp;31, 2008, between Osteotech,
Inc. and Robert Wynalek.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.5</TD>
    <TD width="1%">&nbsp;</TD>
    <TD> Form of Amendment No.&nbsp;1 to Change in Control Agreement, effective as of December&nbsp;31, 2008, between
Osteotech, Inc. and each of Mark H. Burroughs, Robert Honneffer, Sam Owusu&#150;Akyaw and Robert Wynalek.</TD>
</TR>



</TABLE>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">





<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt; text-indent: 4%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="44%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">OSTEOTECH, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Mark H. Burroughs</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD nowrap colspan="2" align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mark H. Burroughs<BR>
Executive Vice President</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="left" style="font-size: 10pt">Date: January&nbsp;7, 2009

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="center" style="font-size: 10pt"><B>EXHIBIT INDEX</B>



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD> Amendment No.&nbsp;2 to Employment Agreement, effective as of December&nbsp;31, 2008, between Osteotech, Inc. and
Mark H. Burroughs.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Amendment No.&nbsp;1 to Employment Agreement, effective as of December&nbsp;31, 2008, between Osteotech,
Inc. and Robert Honneffer.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.3</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Amendment No.&nbsp;2 to Employment Agreement, effective as of December&nbsp;31, 2008, between Osteotech,
Inc. and Sam Owusu&#150;Akyaw.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.4</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Amendment No.&nbsp;1 to Employment Agreement, effective as of December&nbsp;31, 2008, between Osteotech,
Inc. and Robert Wynalek.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.5</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Form of Amendment No.&nbsp;1 to Change in Control Agreement, effective as of December&nbsp;31, 2008, between
Osteotech, Inc. and each of Mark H. Burroughs, Robert Honneffer, Sam Owusu&#150;Akyaw and Robert Wynalek.</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">4




</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c79224e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 14787}]
{"company-data": {"conformed-name": "OSTEOTECH INC", "cik": "0000874734", "assigned-sic": "3841", "irs-number": "133357370", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-19278", "film-number": "09513356"}, "business-address": {"street1": "51 JAMES WAY", "city": "EATONTOWN", "state": "NJ", "zip": "07724", "phone": "7325422800"}, "mail-address": {"street1": "51 JAMES WAY", "city": "EATONTOWN", "state": "NJ", "zip": "07724"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 31, 2008
Osteotech, Inc.
(Exact name of registrant as specified in its charter)
Delaware
000-19278
13-3357370
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
51 James Way, Eatontown, New Jersey
07724
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(732) 542-2800
Not Applicable
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
(e) In October 2004, the American Jobs Creation Act of 2004 amended the Internal Revenue Code of 1986, as amended,
to add Section 409A ("
Section 409A
"), which imposes significant restrictions on non-qualified deferred compensation.
On December 31, 2008, Osteotech, Inc. (the "
Company
") and each of Mark H. Burroughs, Robert Honneffer, Sam Owusu–Akyaw
and Robert Wynalek (each an "
Executive
" and together the "
Executives
") entered into an amendment to each of the
Executive's Employment Agreements and Change in Control Agreements (together, the "
Amendments
") to bring the relevant
provisions of their Employment Agreements and Change in Control Agreements into compliance with Section 409A. The
Amendments (i) clarify the definition of "Separation From Service" for purposes of the Company's payment of amounts
subject to Section 409A, (ii) revise the provisions regarding separation pay due to involuntary separation from service
without cause so that they qualify for the exemption under Section 409A and (iii) clarify when such separation pay
shall be paid.
No other terms or conditions of the Employment Agreements or Change in Control Agreements of each of the
Executives were amended by the Amendments.
The foregoing summary of the Amendments is qualified in its entirety by reference to the Amendments to each of the
Executive's Employment Agreements, which are filed as Exhibits 10.1, 10.2, 10.3 and 10.4 to this Current Report on Form
8-K and incorporated herein by reference, and the form of Change in Control Agreement Amendment, which is filed as
Exhibit 10.5 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
10.1
Amendment No. 2 to Employment Agreement, effective as of December 31, 2008, between Osteotech, Inc. and
Mark H. Burroughs.
10.2
Amendment No. 1 to Employment Agreement, effective as of December 31, 2008, between Osteotech,
Inc. and Robert Honneffer.
10.3
Amendment No. 2 to Employment Agreement, effective as of December 31, 2008, between Osteotech,
Inc. and Sam Owusu–Akyaw.
10.4
Amendment No. 1 to Employment Agreement, effective as of December 31, 2008, between Osteotech,
Inc. and Robert Wynalek.
10.5
Form of Amendment No. 1 to Change in Control Agreement, effective as of December 31, 2008, between
Osteotech, Inc. and each of Mark H. Burroughs, Robert Honneffer, Sam Owusu–Akyaw and Robert Wynalek.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
OSTEOTECH, INC.
By:
/s/ Mark H. Burroughs
Mark H. Burroughs
Executive Vice President
Date: January 7, 2009
EXHIBIT INDEX
10.1
Amendment No. 2 to Employment Agreement, effective as of December 31, 2008, between Osteotech, Inc. and
Mark H. Burroughs.
10.2
Amendment No. 1 to Employment Agreement, effective as of December 31, 2008, between Osteotech,
Inc. and Robert Honneffer.
10.3
Amendment No. 2 to Employment Agreement, effective as of December 31, 2008, between Osteotech,
Inc. and Sam Owusu–Akyaw.
10.4
Amendment No. 1 to Employment Agreement, effective as of December 31, 2008, between Osteotech,
Inc. and Robert Wynalek.
10.5
Form of Amendment No. 1 to Change in Control Agreement, effective as of December 31, 2008, between
Osteotech, Inc. and each of Mark H. Burroughs, Robert Honneffer, Sam Owusu–Akyaw and Robert Wynalek.